K562 cells in plateau phase are equally sensitive to the pro-apoptotic activity of imatinib mesylate (STI571, Gleevec) compared to exponentially growing cells.

被引:0
|
作者
La Rosée, P
Lei, S
Deininger, MW
Druker, BJ
机构
[1] Oregon Hlth Sci Univ, Div Hematol & Med Oncol, Portland, OR 97201 USA
[2] Univ Heidelberg, Fak Klin Med Mannheim, Med Universitatsklin 3, D-6800 Mannheim, Germany
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1229
引用
收藏
页码:317A / 318A
页数:2
相关论文
共 7 条
  • [1] Erythropoietin promotes resistance against the abl tyrosine kinase inhibitor imatinib (STI571) in K562 human leukemia cells
    Kirschner, KM
    Baltensperger, K
    MOLECULAR CANCER RESEARCH, 2003, 1 (13) : 970 - 980
  • [2] Overexpression of P-glycoprotein in K562 cells does not confer resistance to the growth inhibitory effects of imatinib (STI571) in vitro
    Ferrao, PT
    Frost, MJ
    Siah, SP
    Ashman, LK
    BLOOD, 2003, 102 (13) : 4499 - 4503
  • [3] Imatinib mesylate (STI571) abrogates the resistance to doxorubicin in human K562 chronic myeloid leukemia cells by inhibition of BCR/ABL kinase-mediated DNA repair
    Majsterek, I
    Sliwinski, T
    Poplawski, T
    Pytel, D
    Kowalski, M
    Slupianek, A
    Skorski, T
    Blasiak, J
    MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS, 2006, 603 (01) : 74 - 82
  • [4] The effect of imatinib mesylate on the signal transduction cascade leading to down regulation of telomerase activity in K562 cells.
    Mor, Rahav
    Uziel, Orit
    Shpilberg, Ofer
    Lahav, Judith
    Raanani, Pia
    Rabizadeh, Esther
    Lahav, Meir
    Granot, Galit
    BLOOD, 2006, 108 (11) : 280B - 281B
  • [5] In vitro and in silico investigations of the pro-apoptotic activity of Opuntia ficus-indica cladode extracts against K562 cells
    Oncul, Sule
    Becer, Eda
    Mega Tiber, Pinar
    Terali, Kerem
    Aykac, Asli
    TURKISH JOURNAL OF BIOCHEMISTRY-TURK BIYOKIMYA DERGISI, 2024, 49 (04): : 533 - 541
  • [6] A Central Contribution of TG2 Activity to the Antiproliferative and Pro-Apoptotic Effects of Caffeic Acid in K562 Cells of Human Chronic Myeloid Leukemia
    Feriotto, Giordana
    Tagliati, Federico
    Brunello, Arianna
    Beninati, Simone
    Tabolacci, Claudio
    Mischiati, Carlo
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (23)
  • [7] Cotreatment with suberanoylanilide hydroxamic acid and 17-allylamino 17-demethoxygeldanamycin synergistically induces apoptosis in Bcr-Abl+ cells sensitive and resistant to STI571 (imatinib mesylate) in association with down-regulation of Bcr-Abl, abrogation of signal transducer and activator of transcription 5 activity, and bax conformational change
    Rahmani, M
    Reese, E
    Dai, Y
    Bauer, C
    Kramer, LB
    Huang, M
    Jove, R
    Dent, P
    Grant, S
    MOLECULAR PHARMACOLOGY, 2005, 67 (04) : 1166 - 1176